The efficacy and toxicity of rapamycin in murine islet transplantation: In vitro and in vivo studies

Transplantation

Volumn 56, Issue 5, 1993, Pages 1137-1142

  Fabian, M Clifford ^a   Lakey, Jonathan R T ^a   Rajotte, Ray V ^a   Kneteman, Norman M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE HOMEOSTASIS; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMAL; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; POLYENES; SIROLIMUS; SUPPORT, NON-U.S. GOV'T; TISSUE CULTURE;

EID: 0027491723     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199311000-00017     Document Type: Article

References (45)

1. Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22, 989), a new antifungal antibiotic II: fermentation, isolation and characterization. J Antibiot 1975; 28: 727.
2. Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22, 989), a new antifungal antibiotic; I: taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot 1975; 28: 721.
3. Martell PR, Klicius J, Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 1977; 55: 48.
4. Baker H, Sidorowicz A, Sehgal SN, et al. Rapamycin (AY 22-989): a new antifungal antibiotic III: in vitro and in vivo evaluation. J Antibiot (Tokyo) 1978; 31: 539.
5. Eng CP, Sehgal SN, Vezina C. A study of rapamycin (AY 22-989) against transplanted tumors. J Antibiot (Tokyo) 1984; 32: 1231.
6. Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immuno suppressive isolated from a streptomyces. II: immunosuppressive effect of FK 506 in vitro. J Antibiot 1987; 40: 1256.
7. Starzl JE, Todo S, Fung J, et al. FK 506 for liver, kidney and pancreas transplantation. Lancet 1989; 2: 1000.
8. Thomson AW. FK 506: how much potential? Immunol Today 1989; 10: 6.
9. Tanaka H, Kuroda A, Marusawa H, et al. Physicochemical prop erties of FK 506, a novel immunosuppressant isolated from streptomyces tsukubaensis. Transplant Proc 1987; 19 (Suppl 6): 11.
10. Zheng B, Shorthouse R, Masek MA, et al. Effect of the new and highly active immunosuppressant rapamycin on lymphoid tissue and cell in vivo. Transplant Proc 1991; 23: 851.
11. Kay JE, Kromwel L, Doe SEA, Denyer M. Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology 1991; 72: 544.
12. Wicker LS, Boltz RC, Matt V, et al. Suppression of B cell activation by cyclosporine A, FK-506, and rapamycin. Eur J Immunol 1991; 20: 2277.
13. Kuo CJ, Chung J, Fiorentino DF, et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992; 358(6381): 70.
14. Kahan BD, Chang JY, Sehgal SN. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation 1991; 52(2): 185.
15. Morris RE, Wu J, Shorthouse R. A study of the contrasting effects of cyclosporine, FK-506, and rapamycin on the suppression of allograft rejection. Transplant Proc 1990; 22(4): 1638.
16. Eng CP, Gullo-Brown J, Chang JY, Sehgal SN. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide. Transplant Proc 1991; 23(1): 868.
17. Stepkowski SM, Chen H, Daloze P, Kahan BD. Prolongation by Rapamycin of heart, kidney, pancreas and small bowel allograft survival in rats. Transplant Proc 1991; 23(1): 507.
18. Chen HF, Wu JP, Luo HY, Daloze PM. The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat. Transplant Proc 1991; 23(4): 2239.
19. Chen HF, Wu JP, Luo HY, Daloze PM. Reversal of ongoing rejection of allografts by rapamycin. Transplant Proc 1991; 23(4): 2241.
20. Stepkowski SM, Chen H, Daloze P, Kahan BD. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 1991; 51(1): 22.
21. Collier DS, Caine Sir R, Thiru S, et al. Rapamycin in experimental renal allografts in dogs and pigs. Transplant Proc 1990; 22(4): 1674.
22. Collier DS, Caine RY, Pollard SG, et al. Rapamycin in experimen tal renal allografts in primates. Transplant Proc 1991; 23(4): 2246.
23. Gotoh M, Maki T, Kiyoizumi T, et al. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437.
24. Lacy PE, Walker M, Fink C. Perfusion of isolated rat islets in vitro. Diabetes 1972; 21(10): 987.
25. Rajotte R, Warnock G, Evans M, et al. Isolation of viable islets of Langerhans from collagenase-perfused canine and human pan-creata. Transplant Proc 1987; 19: 918.
26. Sutherland DER, Matus AJ, Stiffes MW, Najarian JS. Infant human pancreas: a potential source for islet tissue for transplantation. Diabetes 1976; 25(12): 1123.
27. Warnock GL, Kneteman NM, Ryan EA, et al. Long-term follow up after transplantation of insulin-producing pancreatic islets into patients with type I diabetes. Diabetologia 1992; 35(1): 89.
28. Al-Abdullah IH, Kumar MSA, Abourna GM. Islet transplantation in outbred rats using cyclosporine. Transplant Proc 1990; 22(2): 873.
29. Yasunami Y, Ryu S, Kamei T. FK-506 as the sole immunosup pressive agent for prolongation of islet allograft survival in the rat. Transplantation 1990; 49(4): 682.
30. Stockmann F, Fehmann H-C, Gôke B, et al. Impairment of stim ulated insulin release from the isolated perfused rat pancreas by cyclosporin pretreatment. Transplantation 1989; 48(3): 381.
31. Cattral MS, Warnock GL, Kneteman NM, Rajotte RV. Transplan tation of purified single-donor canine islet allografts with cyclosporin. Transplantation 1989; 47(4): 583.
32. Dresner LS, Anderson DK, Kahng KU, et al. Effects of cyclosporin on glucose metabolism. Surgery 1989; 106(2): 163.
33. Stegall MD, Chabot J, Weber C, et al. Pancreatic islet transplan tation in cynomolgus monkeys. Transplantation 1989; 48(6): 944.
34. Whalstrom HE, Lavelle-Jones M, Endres D, et al. Inhibition of insulin release by cyclosporine and production of peripheral insulin resistance in the dog. Transplantation 1990; 49: 600.
35. Yale J-F, Chamelian M, courchesne S, Vigeant C. Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment. Transplant Proc 1988; 20(3): 985.
36. Alejandro R, Feldman EC, Bloom AD, Kenyon NS. Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles. 1989; 38: 698.
37. Kneteman NM, Marchetti P, Tordjman K, et al. Effects of cyclo sporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants. Surgery 1992; 111(4): 430.
38. Baumgartner D, Schlumpf R, Largiader F. Cyclosporine A inter feres with postoperative blood glucose control after clinical pancreas transplantation. Transplant Proc 1987; 19: 4009.
39. Ricordi C, Zeng YJ, Alejandro R, et al. In vivo effect of FK-506 on human pancreatic islets. Transplantation 1991; 52(3): 519.
40. Carroll PB, Boschero AC, Li MY, et al. Effect of the immunosup pressant FK-506 on glucose-induced insulin secretion from adult rat islets of Langerhans. Transplantation 1991; 51(1): 275.
41. Strasser S, Alejandro R, Shapiro ET, et al. Effect of FK506 on insulin secretion in normal dogs. Metabolism 1992; 41(1): 64.
42. Whiting PH, Adam BJ, Woo J, et al. The effect of rapamycin on renal function in the rat: a comparative study with cyclosporin. Toxicol Lett 1991; 58(2): 169.
43. Whiting PH, Woo J, Adam BJ, et al. Toxicity of rapamycin: a comparative and combination study with cyclosporine at immu-notherapeutic dosage in the rat. Transplantation 1991; 52(2): 203.
44. Draznin B, Metz SA, Sussman KE, Leitner JW. Cyclosporin-induced inhibition of insulin release. Biochem Pharmacol 1988; 37(20): 3941.
45. Chandrasekar B, Mukherjee SK. Effect of prolonged administra tion of cyclosporin A on (pro) insulin biosynthesis and insulin release by rat islets of Langerhans. Biochem Pharmacol 1988; 37(19): 3609.